Verona Pharma plc·4

Aug 7, 9:15 PM ET

Poll Claire 4

4 · Verona Pharma plc · Filed Aug 7, 2023

Insider Transaction Report

Form 4
Period: 2023-08-03
Poll Claire
General Counsel
Transactions
  • Sale

    Ordinary Shares

    2023-08-03$2.54/sh20,608$52,3241,935,231 total
  • Sale

    Ordinary Shares

    2023-08-04$2.50/sh26,352$65,8591,908,879 total
  • Sale

    Ordinary Shares

    2023-08-07$2.47/sh1,512$3,7311,907,367 total
  • Gift

    Ordinary Shares

    2023-08-0789,9761,817,391 total
  • Gift

    Ordinary Shares

    2023-08-07+89,976864,232 total(indirect: By Trust)
Footnotes (5)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported Restricted Share Units.
  • [F3]The price reported represents the sale price of the ADSs divided by eight (8).
  • [F4]Consists of (i) 1,471,672 Ordinary Shares underlying RSUs (which are represented by 183,959 ADSs); (ii) 345,712 Ordinary Shares underlying 43,214 ADSs and (iii) 7 Ordinary Shares.
  • [F5]Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.

Documents

1 file
  • 4
    tm2323103-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT